Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) traded up 10.6% during mid-day trading on Thursday . The stock traded as high as GBX 1.88 ($0.02) and last traded at GBX 1.88 ($0.02). 316,769 shares changed hands during trading, a decline of 74% from the average session volume of 1,235,528 shares. The stock had previously closed at GBX 1.70 ($0.02).
Cizzle Biotechnology Stock Up 10.6 %
The firm’s fifty day moving average is GBX 1.99 and its 200-day moving average is GBX 1.83. The stock has a market capitalization of £7.45 million, a PE ratio of -170.00 and a beta of 0.38.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Read More
- Five stocks we like better than Cizzle Biotechnology
- How to Calculate Inflation Rate
- Is Biotech’s Bull Run Over? Examining Election Impacts
- Breakout Stocks: What They Are and How to Identify Them
- 3 Stocks Generating a Ridiculous Amount of Cash
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Dividend Growth Meets Chips: Top 3 Semiconductor Stocks to Watch
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
